GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » Gross-Profit-to-Asset %

NKY Medical Holdings (SZSE:300109) Gross-Profit-to-Asset % : 20.78% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. NKY Medical Holdings's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥844 Mil. NKY Medical Holdings's average Total Assets over the quarter that ended in Mar. 2024 was ¥4,065 Mil. Therefore, NKY Medical Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 20.78%.


NKY Medical Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for NKY Medical Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings Gross-Profit-to-Asset % Chart

NKY Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.55 10.27 12.24 18.20 23.13

NKY Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.62 25.92 27.67 17.16 20.78

Competitive Comparison of NKY Medical Holdings's Gross-Profit-to-Asset %

For the Drug Manufacturers - General subindustry, NKY Medical Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NKY Medical Holdings's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NKY Medical Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where NKY Medical Holdings's Gross-Profit-to-Asset % falls into.



NKY Medical Holdings Gross-Profit-to-Asset % Calculation

NKY Medical Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=894.387/( (3713.698+4019.691)/ 2 )
=894.387/3866.6945
=23.13 %

NKY Medical Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=844.456/( (4019.691+4109.82)/ 2 )
=844.456/4064.7555
=20.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


NKY Medical Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of NKY Medical Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


NKY Medical Holdings (SZSE:300109) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines